C92.92
Myeloid leukemia, unspecified in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
Myeloid leukemia, unspecified in relapse, is a type of blood cancer that affects the myeloid cells in the bone marrow. These cells normally develop into various types of blood cells, such as red blood cells, white blood cells, and platelets. When leukemia occurs, abnormal myeloid cells multiply rapidly, crowding out healthy blood cells and leading to a range of health issues. The term 'unspecified in relapse' indicates that the exact subtype of myeloid leukemia has not been specified, but the disease has recurred after previous treatment.
Causes & Symptoms
Clinical Causes: Genetic mutations or changes in DNA of myeloid cells Previous exposure to radiation or chemotherapy Family history of blood cancers Exposure to certain toxic chemicals or pollutants Bone marrow disorders that predispose to leukemia Age-related genetic changes
Key Symptoms: Fatigue and weakness due to anemia Frequent infections because of abnormal white blood cells Unexplained fever or chills Easy bruising or bleeding, including nosebleeds or bleeding gums Bone or joint pain Pale skin and shortness of breath Unintentional weight loss Swollen lymph nodes, liver, or spleen
Diagnostic & Treatment
Diagnosis Path: Blood tests to evaluate blood counts and abnormal cells Bone marrow biopsy to examine marrow cells directly Cytogenetic analysis to identify genetic changes in cells Flow cytometry to analyze cell types and markers Molecular testing to detect specific gene mutations Additional imaging studies if organ involvement is suspected
Treatment Protocols: Chemotherapy to destroy abnormal cells and induce remission Targeted therapy that focuses on specific genetic mutations Immunotherapy to boost the body's ability to fight cancer Stem cell or bone marrow transplantation for eligible patients Supportive care, including blood transfusions and antibiotics Clinical trials for new or experimental therapies
Clinical Advice & FAQs
Billing Guidance
Is C92.92 a billable ICD-10 code?
Yes, C92.92 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.92?
Clinical documentation must specify the nature of Myeloid leukemia, unspecified in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference